Cite
HARVARD Citation
Houssel‐Debry, P. et al. (2018). 12 Weeks of a Ribavirin‐Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation. Hepatology. 68 (4), pp. 1277-1287. [Online].